Search

Dennis Ostrovsky assists clients with patent portfolios involving obtaining patents in diverse technologies such as nanomaterials, cellular analysis systems, small molecule drugs, bactericides, abrasives, drug delivery systems, dental compositions, volumetric additive manufacturing (VAM), OLED...

A patent attorney with a Ph.D. in Molecular Biology and Microbiology, Alireza Behrooz assists companies and universities in protecting intellectual property connected to inventions in the life sciences. Drawing on years of private practice experience, Alireza prepares, files and secures patents as...

George Naya is a seasoned corporate lawyer with a broad practice centered on U.S. securities laws and corporate governance. He advises companies in a diverse array of industries and has extensive experience in both domestic and international capital markets transactions. In addition to his time in...

Jason McElroy is a trial lawyer with nearly 20 years of experience representing clients in complex litigation in federal and state courts. He has obtained verdicts and judgments in jury trials, bench trials and arbitration proceedings throughout the country. Jason litigates a wide range of matters...

Monaf Awwa, Ph.D., is a patent agent who helps clients in the biopharmaceutical, medical device and chemical industries protect their intellectual property by drafting their patent applications, preparing USPTO office action responses, and handling patent prosecutions. He also provides clients with...

Brandon Sherman devotes his practice to advising institutions of higher education, accreditation agencies, and educational companies that support their missions. Drawing on a combination of legal experience from private practice and government roles at the U.S. Department of Education, Brandon’s...

Kevin M. Levy focuses primarily on real estate matters, including property sales and acquisitions, leases, commercial real estate lending and borrowing, development projects and real estate tax appeals. Kevin also advised clients on COVID-19 regulatory compliance and has commented extensively on...